Professor Bulent Berkarda is a pioneering figure in the field of medical oncology, renowned as the first medical oncologist in Turkey. With a career spanning several decades, his contributions have left an indelible mark on both the medical community and the lives of countless patients.
Born with a passion for healing, Prof. Berkarda embarked on his journey in medicine, graduating with distinction from Istanbul University, School of Medicine. His unwavering dedication to patient care led him to specialize in oncology at University of Rochester, USA a field that was not yet established in Turkey at the time.
Over the years, Prof. Berkarda’s tireless efforts transformed the landscape of oncology in Turkey. He founded the Department of Medical Oncology at Istanbul University in 1974, the first department of medical oncology of Turkey. He also played a pivotal role in establishing the Turkish Society of Oncology and the Turkish Society of Chemotherapy. His commitment to improving cancer care led to improved survival rates and a higher quality of life for patients across the country.
In addition to his clinical work, Prof. Berkarda is a respected educator, mentoring generations of aspiring oncologists. He served as the Dean of Cerrahpasa Medical Faculty (1979 – 1982) and the President of Istanbul University (1994 – 1998). His academic contributions, including numerous publications and lectures, have earned him international recognition.
Since 2010, Prof. Berkarda has focused on researching complementary methods of cancer treatment to be used alongside the standard orthodox therapeutic protocols, especially for Stage IV patients for who chemotherapy alone is usually ineffective. More specifically, he has been investigating the roles of diet, nutraceuticals, hyperthermia and insulin potentiated chemotherapy to balance the limitations of standard treatment protocols.
Today, Prof. Berkarda stands as a symbol of excellence in the field of medical oncology in Turkey, leaving a lasting legacy of compassion, innovation, and hope for patients and healthcare professionals alike.
Associate Professor Mehmet Salih İyikesici, a dedicated and visionary medical oncologist, has committed his career to advancing the field of cancer care and bringing hope to patients facing this formidable adversary. His journey into oncology was inspired by a deep passion for making a difference in the lives of those touched by cancer.
After completing his medical training at Uludag University, School of Medicine in Bursa, Assoc. Prof. İyikesici completed his Internal Medicine residency at Haydarpasa State Hospital and he then pursued a specialization in medical oncology at Marmara University, School of Medicine, seeking the highest levels of expertise in the fight against cancer. He also founded the Medical Oncology Department at Diyarbakır State Hospital and undertook advanced training in hyperthermia at centers in Germany and Switzerland, immersing himself in the latest breakthroughs in oncological research and treatment.
Assoc. Prof. İyikesici’s patient-centric approach is marked by empathy and innovation. He has been a tireless advocate for integrating cutting-edge research into clinical practice, ensuring that his patients have access to the most advanced and effective cancer therapies available.
As a prolific researcher, Assoc. Prof. İyikesici has made significant contributions to the field of medical oncology together with Prof. Berkarda and Dr. Slocum, publishing groundbreaking studies that have advanced our understanding of cancer and its treatments.
Assoc. Prof. İyikesici’s career is defined by his unwavering commitment to improving the lives of cancer patients. He stands as a beacon of hope, ushering in a new era of compassionate, research-driven cancer care, and saving countless lives along the way.
Dr. Abdul Kadir Slocum M.D. is originally from the United States, but grew up in Turkey and completed his medical training at Marmara University, Istanbul. He is an oncologist dedicated to improving his patients’ outcomes with innovative treatment modalities and integrative therapeutic approaches. Drawing on his many years’ experience, he combines evidence-based complementary and metabolic therapies with conventional cancer treatments for optimal patient outcomes.
Dr. Slocum believes in treating the whole person, addressing not only the physical aspects of cancer but also the emotional, psychological, and spiritual dimensions. He recognizes that a cancer diagnosis can have a profound impact on a patient’s overall health and quality of life, and he is dedicated to providing comprehensive care that supports the body, mind, and spirit.
In his practice, Dr. Slocum integrates complementary and metabolic therapies such as hyperthermia, hyperbaric oxygen therapy, ozone therapy, repurposed drugs, ketogenic diet and other metabolic therapies into personalized treatment plans and keeps up-to-date with the latest research to deliver the latest evidence-based practice. He values transparent communication with his patients and involves them in shared decision-making, empowering them throughout their journeys.
Beyond his clinical work, Dr. Slocum contributes to research and community outreach, raising awareness and increasing education about integrative oncology and metabolic cancer treatment. With his commitment to patient-centered care and the integration of conventional cancer treatment with science-based complementary and metabolic therapies, Dr. Slocum continually strives to improve his patients’ well-being and treatment outcomes.